Bangkok Dusit Medical Services Public Company Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bangkok Dusit Medical Services Public Company Limited generated cash of $20,778,386,590, which is more than the previous year. Cash used in financing activities reached the amount of -$17,897,400,033 last year. Net change in cash is therefore -$4,873,181,456.
Cash Flow
| 2014 | 10.37B | -16.15B | 5.31B |
|---|---|---|---|
| 2015 | 12.86B | -5.18B | -5.76B |
| 2016 | 12.44B | -9.49B | -4.26B |
| 2017 | 10.93B | -11.86B | 1.81B |
| 2018 | 14.80B | -13.35B | -1.51B |
| 2019 | 14.54B | 2.81B | -17.70B |
| 2020 | 11.68B | 12.38B | -9.09B |
| 2021 | 14.56B | -4.76B | -18.53B |
| 2022 | 20.26B | -5.90B | -12.63B |
| 2023 | 20.77B | -7.75B | -17.89B |
BDULF Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 12.66B | 10.93B | 19.66B | 4.69B | 5.03B | 5.09B | 4.21B | 5.52B | 3.60B | 4.06B |
Operating activities | ||||||||||
Net income | 18.65B | 16.48B | 10.59B | 10.40B | 19.88B | 12.38B | 13.13B | 10.69B | 10.09B | 9.34B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 5.84B | 5.94B | 6.32B | 6.41B | 5.75B | 5.38B | 5.16B | 4.80B | 4.38B | 3.70B |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.24B | -1.52B | -2.11B | 1.45B | -1.49B | -768.98M | -830.68M | 341.93M | -851.64M | -860.07M |
Inventories | -239.04M | -340.84M | -168.59M | -21.39M | -95.07M | -65.45M | -226.46M | -232.85M | -177.45M | -79.97M |
Accounts payable | 133.03M | 932.15M | 687.49M | -592.08M | 77.09M | 380.48M | -397.37M | 388.30M | 164.25M | 402.30M |
Cash generated by operating activities | 20.77B | 20.26B | 14.56B | 11.68B | 14.54B | 14.80B | 10.93B | 12.44B | 12.86B | 10.37B |
Investing activities | ||||||||||
Purchases Of Investments | -84M | -1.11B | -493.31M | -369.67M | -73.12M | -241.55M | -23.56M | -519.78M | 522.87M | -1.75B |
Investments In Property Plant And Equipment | -7.74B | -5.07B | -4.37B | -6.64B | -7.99B | -7.69B | -15.60B | -8.97B | -6.34B | -8.00B |
Acquisitions Net | 0 | 862.62K | 21.39M | 18.74B | 12.56B | -5.96B | -1.34B | 23.49M | -1.57B | -7.44B |
Cash generated by investing activities | -7.75B | -5.90B | -4.76B | 12.38B | 2.81B | -13.35B | -11.86B | -9.49B | -5.18B | -16.15B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.47B | 45.72M | 18.87B |
Payments for dividends | -10.34B | -7.94B | -12.73B | -4.74B | -6.94B | -5.59B | -4.95B | -5.57B | -3.56B | -3.09B |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -21.89M | -168.94M | 0 | -75.64M |
Repayments of term debt | -6.86B | -2.65B | -5.59B | -9.12B | -10.49B | -1.48B | 6.91B | -10.60B | -2.10B | -10.19B |
Cash used in financing activities | -17.89B | -12.63B | -18.53B | -9.09B | -17.70B | -1.51B | 1.81B | -4.26B | -5.76B | 5.31B |
Net Change In Cash | -4.87B | 1.73B | -8.73B | 14.97B | -337.30M | -57.63M | 874.32M | -1.31B | 1.92B | -467.00M |
Cash at end of period | 7.79B | 12.66B | 10.93B | 19.66B | 4.69B | 5.03B | 5.09B | 4.21B | 5.52B | 3.59B |